4 recalls found for Granules Pharmaceuticals Inc.. Check if any of your products are affected.
Granules Pharmaceuticals Inc. recalled 71,424 bottles of Trazodone Hydrochloride on January 26, 2026. The recall stems from the presence of foreign tablets or capsules in the product. Consumers should stop using the medication immediately and consult their healthcare provider.
Granules Pharmaceuticals Inc. recalled 3,384 bottles of amphetamine capsules on August 28, 2025. The recall follows a failure to meet impurities and degradation specifications. Consumers should stop using this product immediately and consult healthcare providers.
Granules Pharmaceuticals Inc. recalled 11,895 bottles of extended-release capsules on August 28, 2025. The capsules failed impurities and degradation specifications. Consumers should stop using the product immediately, as it could pose health risks.
Granules Pharmaceuticals Inc. recalled 11,909 bottles of Dextroamphetamine extended-release capsules on August 28, 2025. The recall stems from failure to meet impurities and degradation specifications. Healthcare providers and consumers must stop using the product immediately.